SMARCA2/4 PROTAC DEGRADATION
Join the next opnMe.com Online Seminar November 29, 2022 – 4 pm CET / 10 am EST – The journey of an opnMe PROTAC, from bench to a new therapeutic...
Meet Boehringer Ingelheim’s opnMe team
Inospin invites Technology Transfer Officers & Investigators to an exclusive webinar with Boehringer Ingelheim’s opnMe team. Inospin and Boehringer Ingelheim have been collaborating for more than four years on various...
External collaboration in cosmetics industry with Avon
In this episode, Jolanta Idelbak Baldys, Research Fellow at Avon’s New Technology Department will share her experience in external collaboration. Jolanta joined Avon in 2010 and has over 15 years...
Immortal cells and academia-industry collaboration
In this episode Dr. Collins talks about the differences of approaches of industry-academia collaboration, immortalization of cells and the importance of commercialization for researchers. Dr. Daniel Collins has over 30...
The importance of external collaboration in agricultural industry
In this episode of Inospin interviews, we had a discussion with Dr. Mary McEvoy, Technical Development Manager at Germinal Ireland, the seventh generation family company formed in 1825. Germinal is...
Boehringer Ingelheim, about its collaboration with academia on new drug development
For the past 2 years Inospin has been working with Boehringer Ingelheim and the opnMe team regarding multiple industry-academia collaboration programs. One of their first collaboration resulted in a publication...
The importance of Academia-Industry Collaboration
Dr. Faiz Ahmad is a Professor and the Head of Centre for Advanced and Functional Materials at the Universiti Teknologi PETRONAS (UTP), a leading private university in Malaysia established in...
Various approaches in problem solving for industry and academia cooperation
The Materials Science Institute of Mulhouse (IS2M) leads a multidisciplinary research in materials science with high-level expertise in chemistry and physics of surfaces and interfaces and in the field of...
Thorough description of risks & challenges of academia-industry collaboration and in-depth advices to have a successful collaboration
Aitiip Technology Centre is a private foundation whose patronage is composed of large companies in the plastic processing sector. Thanks to Inospin, the Aitiip managed to set a collaboration with...
Critical thinking about real value of innovations, ressources alignment and shared vision are keys to a successful collaboration
Lincoln Agritech, a research and development company owned by Lincoln University (New Zealand), has established a collaboration with a global FMCG corporation through the intermediation of Inospin. Dr Rob Kelly,...
External innovation to replace synthetic chemical technologies with natural alternatives
Janssen PMP is a division of Janssen Pharmaceutica (Johnson & Johnson) specialized on postharvest treatment (shelf life of fruits and vegetables) and microbial control (plastics, anti-fooling and wood protection). With...
Collaborating with Start-ups, Academia and Suppliers
Essilor is the world's leading ophthalmic optics company with Headquarters in France. The company designs, manufactures and markets lenses to improve and protect eyesight. Dr. Feuillade, explains how Essilor collaborates...
Collaboration with Academia to expend in-depth knowledge, beyond short term applications
Interview with Jules Roelofs, Global Innovation Manager at Holland Colours, Holland Colours is a multinational company headquartered in the Netherlands. The company develops liquid and solid colorants and additives for...
Collaborating with industry to make an effective societal impact
Dr Bansal explains how her group, The Liver Lab at the University of Twente (NL) foresees collaborating with industry to make an impact on the society and reviews the critical...
Drug discovery in big pharma – collaborating with academia
Dr Pastoureau explains how collaborating with academia and start-ups is essential for Drug discovery in Big Pharma. Dr. Pastoureau also comments on his experience with Inospin and how the platform...
Collaborating with industry as a consultant to provide expert opinion
Dr Palmer explains how he was involved as a consultant on pharmaceutical drug development, interpretation of experimental results, perform research experiments and associated issues.
Collaborating with industry, a critical step into broader patient care
Dr Bleier explains why for him working with Industry is a critical step to advancing investigator-initiated work to broader patient care.
Michael Donabedian presents how Vetoquinol collaborates with Academic partners
Michael Donabedian presents how Vetoquinol collaborates with Academic partners
External innovation and collaboration with Academia
External innovation and collaboration with Academia
Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface
In response to the dual challenges of increasingly risky target portfolios and realignment of traditional pharmaceutical company resources away from early-phase research and development (R&D), research groups have sought to...